)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
PTC Therapeutics (PTCT) investor relations material
PTC Therapeutics Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary18 Nov, 2025
Commercial and clinical highlights
SEPHIENCE, an oral therapy for PKU, launched globally after July approval, with strong initial revenue and broad prescriber adoption across all patient ages and severities.
SEPHIENCE demonstrated significant efficacy, enabling 97% of patients to liberalize their diet and two-thirds to reach normal protein intake, addressing major unmet needs in PKU.
Early launch generated $19.6 million in six weeks, with rapid uptake in the U.S. and Germany and positive feedback from physicians aiming to prescribe SEPHIENCE to all PKU patients.
Market access has been favorable, with minimal payer restrictions and broad label coverage in both the U.S. and Europe.
European launch strategy focuses on maintaining a consistent pricing corridor, with launches sequenced to support pricing integrity; Japan and Brazil launches are planned soon.
Launch metrics and financial outlook
Key launch metrics include total revenue (broken out by region), patient start forms, number of patients on therapy, and payer mix, with two-thirds of PKU patients on commercial insurance.
Revenue guidance for the year is $750–$800 million, with operating expenses at $730 million; profitability is expected soon, driven by SEPHIENCE's multi-billion dollar potential.
OpEx is expected to decrease as expensive trials conclude, supporting the path to profitability.
Pipeline and competitive positioning
DMD franchise remains resilient post-generic entry, retaining over 70% of peak revenue due to brand loyalty and strong patient support services.
Vatiquinone for Friedreich's ataxia is under FDA discussion for resubmission pathways, with a focus on unmet needs in pediatric and adolescent patients.
Huntington's disease program (PTC518) showed positive phase 2 results; upcoming FDA meeting will address confirmatory trial design and potential for accelerated approval.
Upcoming R&D day will highlight progress in splicing and inflammation platforms, including preclinical and early clinical programs.
Safiance: How to prioritize patient segments?
Safiance global pricing corridor strategy?
PTC518: FDA view on accelerated approval?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next PTC Therapeutics earnings date
Status Update2 Dec, 2025
Next PTC Therapeutics earnings date
Status Update2 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PTC Therapeutics Inc is a biopharmaceutical company focused on discovering, developing, and commercializing treatments for rare disorders. The company uses proprietary platforms to develop small molecules and gene therapies. Its portfolio targets genetic disorders, oncology, and neurological conditions. The company is headquartered in South Plainfield, New Jersey, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage